01—History
Accounts Receivable History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $184.0M
1 older move runs past ±150% (largest +25808.0%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is Moderna, Inc.'s current accounts receivable?
Moderna, Inc. (MRNA) annual accounts receivable for 2025 was $184.0M, a 48.60% decline from 2024. Moderna, Inc. accounts receivable for the quarter ending March 31, 2026 was $71.0M.
What was Moderna, Inc.'s accounts receivable in 2024?
Moderna, Inc. annual accounts receivable for 2024 was $358.0M, a 59.87% decline from 2023.
What was Moderna, Inc.'s accounts receivable in 2023?
Moderna, Inc. annual accounts receivable for 2023 was $892.0M, a 35.60% decline from 2022.
What is Moderna, Inc.'s 5-year accounts receivable CAGR?
Moderna, Inc. accounts receivable grew at a compound annual growth rate (CAGR) of 33.27% from FY2020 to FY2025, going from $1.39B to $184.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)